Article

COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study

2021-08-09

Abstract excerpt

<h4>Objective</h4> Patients with immune-mediated diseases treated with CD20 inhibitors may have worse COVID-19 outcomes due to impaired humoral immunity, but differences versus the general population are unknown. <h4>Methods</h4> We identified patients with immune-mediated diseases who received CD20 inhibitors within one year prior to the index date of PCR-confirmed COVID-19 between January 31, 2020, and January 3...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 342f6645-e075-582f-b46c-c02e617b4807
DOI: 10.1101/2021.08.05.21261643

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort StudyDOI 10.1101/2021.08.05.21261643Read

Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platformSemantic proximity Read

Clinical Outcomes of Patients Previously Treated with B-Cell Depletion Therapy Hospitalized with COVID-19: Results from the Johns Hopkins Crown RegistrySemantic proximity Read

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron EraSemantic proximity Read

Higher Rates of COVID-19 but Less Severe Infections Reported for Patients on Il-4/Il-13 Blocker: A Big Data Analysis of the WHO VigibaseSemantic proximity Read

A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic DiseasesSemantic proximity Read

Covid 19 Infection in Patients with Rheumatic Immune-Mediated Diseases in a Single University Hospital. Matched Case-Control Study and Literature Review.Semantic proximity Read

Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine LearningSemantic proximity Read

Immune targeted therapies for COVID-19 Infection: A Promising OutlookSemantic proximity Read

COVID-19-neutralizing antibodies predict disease severity and survivalSemantic proximity Read

No Increased Lethality in Covid-19 in Patients with Inflammatory Rheumatic Diseases Compared to the General Population - a Comparison of Two German Registries -Semantic proximity Read

Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort StudySemantic proximity Read

Associations of DMT Therapies with COVID-19 Severity in Multiple Sclerosis: An International Cohort StudySemantic proximity Read